Recent news highlights include Elevance Health surpassing Q1 earnings and revenue expectations, revising its annual earnings guidance, and conducting its Q1 2026 earnings conference call. Market conditions such as crude price volatility have influenced broader stock movements around the company.

• Elevance Health held its Q1 2026 earnings conference call on April 22, 2026 [N1].
• The company reported Q1 earnings and revenue that surpassed expectations in April 2026 [N2].
• Elevance Health revised its annual earnings guidance in April 2026 [N3].
• Stock market activity around the company was affected by crude price jumps and geopolitical concerns in April 2026 [N4].
• Pre-market reports on April 22, 2026, included Elevance Health among companies releasing earnings [N5].
• Wall Street insights on Elevance Health's Q1 earnings highlighted key metrics in mid-April 2026 [N6].
• Concerns about health benefits weakness potentially impacting Q1 earnings were discussed in April 2026 [N7].
• Discussions on medical membership trends and their effects on earnings were noted in related healthcare coverage [N8].

Elevance Health benefits from a large and diversified membership base and a comprehensive suite of health insurance and related services, including specialty pharmacy and care management. The company's operating model transformation program targets improved efficiency and technology modernization, which could enhance operational effectiveness. Recent quarterly results show strong revenue generation and profitability, with the company revising its annual earnings guidance, indicating active management of financial targets. Its status as a Blue Cross and Blue Shield licensee across multiple states supports brand recognition and market access.

Risks to Elevance Health include exposure to healthcare cost inflation and utilization trends that can pressure margins. Regulatory changes at federal and state levels affecting healthcare, insurance, and pharmacy services could impact operations and financial results. The company is undertaking a significant operating model transformation that involves workforce reductions and IT modernization, which carries execution risks and potential disruption. Market volatility and investment portfolio risks may affect net investment income. Competitive pressures in the health insurance market and changes in membership dynamics could also pose challenges.

Elevance Health's moat is supported by its large and diversified medical membership base of over 45 million members, extensive geographic footprint as a Blue Cross and Blue Shield licensee in multiple states, and a broad portfolio of managed care and specialty health services. Its integrated platform combining risk-based insurance plans with pharmacy and health services through Carelon businesses creates operational synergies and customer stickiness. The company's scale and regulatory licenses provide barriers to entry, while its ongoing transformation program aims to improve cost efficiency and service delivery, reinforcing competitive positioning.

• Healthcare Cost and Utilization Trends: Elevance Health faces risks from rising healthcare costs and changes in utilization rates that may affect profitability and premium pricing.
• Regulatory and Legislative Changes: Changes in federal, state, or international laws and regulations related to healthcare, insurance, and pharmacy services could materially impact the company's business model and financial results.
• Operating Model Transformation Execution: The ongoing 2026-2027 Operating Model Transformation Program involves workforce reductions and IT modernization, which carry risks of execution delays, cost overruns, and operational disruption.
• Investment Portfolio and Market Risks: Fluctuations in investment income and potential impairments in the company's investment portfolio may affect overall financial performance.
• Competitive and Membership Dynamics: Competitive pressures and changes in medical membership levels, including potential declines, could impact revenue and market share.

• Elevance Health, Inc. is a large U.S.-based health insurer serving approximately 45.4 million medical members as of March 31, 2026.
• The company operates through affiliated health plans offering network-based managed care risk-based plans across Individual, Employer Group, Medicaid, and Medicare markets.
• It also provides managed care services to fee-based customers including claims processing, stop loss insurance, care provider network access, medical management, care management, wellness programs, actuarial services, and other administrative services.
• Revenue is generated from risk-based premiums, administrative fees from self-funded employers, and pharmacy and health service fees through its Carelon businesses.
• Elevance Health is an independent licensee of the Blue Cross and Blue Shield Association, operating in multiple states under brands such as Anthem Blue Cross/Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon.
• The company reports four operating segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
• For the quarter ended March 31, 2026, Elevance Health reported total revenues of approximately $50.18 billion, including premiums of $41.02 billion, product revenue of $6.23 billion, and service fees of $2.25 billion.
• Net income for Q1 2026 was $1.76 billion, with basic earnings per share of $8.03 and diluted EPS of $8.00.
• The company’s balance sheet as of March 31, 2026, shows cash and cash equivalents of $9.66 billion, current assets of $67.03 billion, and current liabilities of $45.31 billion, resulting in a current ratio of 1.48 and a cash ratio of 0.21.
• Elevance Health has implemented a 2026-2027 Operating Model Transformation Program aimed at streamlining operations, reducing organizational layers, and modernizing IT platforms, with related costs recognized in Q1 2026.
• Recent news indicates the company surpassed Q1 earnings and revenue expectations and revised its annual earnings guidance in April 2026.
• The company’s stock price was approximately $337.76 as of February 6, 2026.
• Elevance Health provides specialty services including pharmacy services, stop loss insurance, dental, vision, supplemental health insurance benefits, and integrated health services.
• The company serves federal government programs including the Federal Employee Program (FEP).